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The need to find new and better anticancer drugs is inexorable. Therefore, a good knowledge of the different and more frequent
resistance mechanisms that have been discovered is vital, emphasizing the need to act in CSCs. The ideal would be to be able
to individualize each case as much as possible to seek the development of combined and personalized treatments that are
effective, safe and definitive for the patient, whether human or animal.
The chaotic nature of cancer makes its reaction to the different drugs unpredictable as they manage to evade its effects thanks
to resistance mechanisms by specific and nonspecific methods. Furthermore, these resistances can range from a simple amino
acid change, to drastic alterations in the expression of protein sets, important for cell behavior and vital functions.
Provide an updated overview of the different and most important mechanisms of cancer resistance against antitumor drugs,
mainly chemotherapeutics, in order to improve the development of therapies and the design of new drugs.
Introduction
Conclusion
CSCs are present in most cancers and are one of the main reasons
of relapses due to their qualities as a stem cell that give them a high
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